Excite Pharma Services
Generated 5/10/2026
Executive Summary
Excite Pharma Services is a US-based contract research and manufacturing organization (CRO/CDMO) that provides comprehensive chemistry, manufacturing, and controls (CMC) services. Founded in 2010 and headquartered in New York, the company specializes in aseptic manufacturing and analytical chemistry, supporting pharmaceutical clients from small-scale development through commercial production. Operating under FDA-inspected, cGMP/GLP-compliant standards, Excite Pharma serves drug substance, drug product, and excipient development needs. The company targets mid-tier and emerging pharma firms seeking reliable, high-quality outsourced CMC capabilities. With a focused service offering and regulatory compliance, Excite Pharma is positioned to capture demand in the growing outsourced drug development market, though its private status limits visibility into financial performance and competitive differentiation.
Upcoming Catalysts (preview)
- Q2 2026Successful completion of FDA facility inspection or re-certification85% success
- Q3 2026Announcement of new strategic client partnership or multi-year contract60% success
- Q4 2026Expansion of manufacturing capacity or introduction of new aseptic filling line50% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)